AI-generated from publicly available materials.Tata Consultancy Services (TCS) has launched TCS ADD AgentHub, an AI platform aimed at enhancing the efficiency of pharmaceutical companies in clinical trials and drug development.
The TCS ADD AgentHub acts as an intermediary AI agent layer within TCS's existing clinical research suite. It is designed to automate repetitive tasks such as data extraction and document review, allowing human teams to focus on governance and decision-making. This model, referred to as the Human + AI Operating Model, emphasizes oversight and compliance, crucial for regulated pharmaceutical environments.
Key functionalities of AgentHub include clinical data review, study design, and drug safety case processing. TCS claims that its solutions have led to significant efficiency gains, reporting up to a 40% improvement in clinical data management and a 30% reduction in study build efforts. However, these figures are based on internal assessments and have not been independently verified.
The platform operates on Google Cloud’s Gemini Enterprise infrastructure and aims to bridge data silos often found in clinical research. With the agentic AI market in pharmaceuticals projected to reach $6.16 billion by 2026, TCS is positioning AgentHub as a crucial step for companies transitioning from AI experimentation to scalable and auditable implementations.